Codiak’s Versatile engEx™ Platform for Engineered Exosomes Published in the Journal Molecular Therapy

NEXT STORY
Outlook on the Biosimilars Global Market to 2026 – Patent Expirations of Major Biologics Leads Way for Biosimilars
PREV STORY
Merus Announces Pricing of Public Offering of Common Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Philadelphia CRO Acquired by Investment Fund; Relaunched InClinica Poised for Global Growth

PHILADELPHIA, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Velocity Fund Partners, a Pittsburgh private equity ...

author_avatar
NASDAQ Market News

DIAGNOS Adds a Second Screening Site at the CHUM in the Ophthalmology Department

author_avatar
NASDAQ Market News

GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19

author_avatar
NASDAQ Market News